Antimicrobial resistance and antimicrobial use associated with laboratory-confirmed cases of Campylobacter infection in two health units in Ontario

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 24, Issue 1, 2013, Pages

  Deckert, Anne E ^a,b   Reid Smith, Richard J ^a,b   Tamblyn, Susan E ^f   Morrell, Larry ^c   Seliske, Patrick ^d   Jamieson, Frances B ^e   Irwin, Rebecca ^b   Dewey, Catherine E ^a   Boerlin, Patrick ^a   McEwen, Scott A ^a  

^a UNIVERSITY OF GUELPH   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c Perth District Health Unit   (Canada)

^d Wellington Dufferin Guelph Public Health Ontario   (Canada)

^e PUBLIC HEALTH ONTARIO   (Canada)

^f NONE

Author keywords

Antimicrobial resistance; Antimicrobial use; Campylobacter; Canada; Ontario

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFALEXIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; METRONIDAZOLE; NALIDIXIC ACID; SULFONAMIDE; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CAMPYLOBACTER; CAMPYLOBACTERIOSIS; CANADA; CHILD; DIARRHEA; DRUG USE; EPSILOMETER TEST; FECES CULTURE; FEMALE; FEVER; HEALTH CENTER; HOME CARE; HOSPITALIZATION; HUMAN; INFANT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 84878274359     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2013/176494     Document Type: Article

References (62)

1. Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect 2004;10:868-76.
2. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. St Louis: Mosby, 1998.
3. Government of Canada. Notifiable diseases on-line. 〈http://dsol- smed.phac-aspc.gc.ca/dsol-smed/ndis/index-eng.php〉 (Accessed November 1, 2012).
4. Centers for Disease Control and Prevention (CDC). Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, 2009. Morb Mortal Wkly Rep 2010;59:418-22.
5. Flint JA, Doré K, Majowicz SE, Edge VL, Sockett P. From stool to statistics: Reporting of acute gastrointestinal illnesses in Canada. Can J Public Health 2004;95:309-13. (Pubitemid 39107003)
6. Majowicz SE, Edge VL, Fazil A, et al. Estimating the underreporting rate for infectious gastrointestinal illness in Ontario. Can J Public Health 2005;96:178-81. (Pubitemid 40779041)
7. .Thomas KM, Majowicz SE, Sockett PN, et al. Estimated numbers of community cases of illness due to Salmonella, Campylobacter and verotoxigenic Escherichia coli: Pathogen-specific community rates. Can J Infect Dis Med Microbiol 2006;17:229-34. (Pubitemid 44519745)
8. Swartz MN. Human diseases caused by foodborne pathogens of animal origin. Clin Infect Dis 2002;34(Suppl 3):S111-22. (Pubitemid 34553690)
9. Haagsma JA, Siersema PD, DE Wit NJ, Havelaar AH. Disease burden of post-infectious irritable bowel syndrome in the Netherlands. Epidemiol Infect 2010;138:1650-6.
10. Thabane M, Marshall JK. Post-infectious irritable bowel syndrome. World J Gastroenterol 2009;15:3591-6.
11. Allos BM. Campylobacter jejuni infections: Update on emerging issues and trends. Clin Infect Dis 2001;32:1201-6. (Pubitemid 32381123)
12. Blaser MJ, Engberg J. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. In: Nachamkin I, Szymanski CM, Blaser MJ, eds. Campylobacter, 3rd edn. Washington, DC: ASM Press, 2008:99.
13. Guerrant RL, Van Gilder T, Steiner TS, et al. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-51. (Pubitemid 32173618)
14. Kapperud G, Lassen J, Ostroff SM, Aasen S. Clinical features of sporadic Campylobacter infections in Norway. Scand J Infect Dis 1992;24:741-9. (Pubitemid 23047106)
15. Gupta A, Nelson JM, Barrett TJ, et al. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis 2004;10:1102-9. (Pubitemid 38697705)
16. Nelson JM, Smith KE, Vugia DJ, et al. Prolonged diarrhea due to ciprofloxacin-resistant Campylobacter infection. J Infect Dis 2004;190:1150-7. (Pubitemid 39186803)
17. Schonberg-Norio D, Mattila L, Lauhio A, et al. Patient-reported complications associated with Campylobacter jejuni infection. Epidemiol Infect 2010;138:1004-11.
18. Helms M, Simonsen J, Olsen KEP, Molback K. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: A registry-based cohort study. J Infect Dis 2005;191:1050-5. (Pubitemid 40404362)
19. Engberg J, Neimann J, Nielsen EM, Aarestrup FM. Quinolone-resistant Campylobacter infections in Denmark: Risk factors and clinical consequences. Emerg Infect Dis 2004;10:1056-63. (Pubitemid 38697698)
20. Smith KE, Besser JM, Hedberg CW, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. N Engl J Med 1999;340:1525-32. (Pubitemid 29228180)
21. Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) 2007. Guelph: Government of Canada, 2010.
22. Lo Re V. Infectious diseases: Hot topics. Philadelphia: Hanley and Belfus, 2004.
23. Karmali MA, Fleming PC. Campylobacter enteritis in children. J Pediatr 1979;94:527-33. (Pubitemid 9125339)
24. Anders BJ, Lauer BA, Paisley JW, Reller LB. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis. Lancet 1982;1:131-2. (Pubitemid 12194205)
25. Pai CH, Gillis F, Tuomanen E, Marks MI. Erythromycin in treatment of Campylobacter enteritis in children. Am J Dis Child 1983;137:286-8. (Pubitemid 13143093)
26. Mandal BK, Ellis ME, Dunbar EM, Whale K. Double-blind placebo-controlled trial of erythromycin in the treatment of clinical Campylobacter infection. J Antimicrob Chemother 1984;13:619-23. (Pubitemid 15087833)
27. Public health considerations of infectious diseases in child day care centers. The Child Day Care Infectious Disease Study Group. J Pediatr 1984;105:683-701.
28. Ashkenazi S, Danziger Y, Varsano Y, Peilan J, Mimouni M. Treatment of Campylobacter gastroenteritis. Arch Dis Child 1987;62:84-5. (Pubitemid 17222204)
29. Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. J Infect Dis 1997;176(Suppl 2):S103-5. (Pubitemid 27505870)
30. Kapperud G, Aasen S. Descriptive epidemiology of infections due to thermotolerant Campylobacter spp. in Norway, 1979-1988. APMIS 1992;100:883-90.
31. King CK, Glass R, Bresee JS, Duggan C; Centers for Disease Control and Prevention. Managing acute gastroenteritis among children: Oral rehydration, maintenance, and nutritional therapy. MMWR Recomm Rep 2003;52:1-16.
32. Aberg JA, Goldman MP, Gray LD, Long JK. Infectious diseases handbook. Canada: Lexi-Comp, 2006.
33. Razavi B, Apisarnthanarak A, Mundy LM. Clostridium difficile: Emergence of hypervirulence and fluoroquinolone resistance. Infection 2007;35:300-7. (Pubitemid 47502344)
34. Luber P, Wagner J, Hahn H, Bartelt E. Antimicrobial resistance in Campylobacter jejuni and Campylobacter coli strains isolated in 1991 and 2001-2002 from poultry and humans in Berlin, Germany. Antimicrob Agents Chemother 2003;47:3825-30. (Pubitemid 37484996)
35. Karmali, De Grandis, Fleming. Antimicrobial susceptibility of Campylobacter jejuni with special reference to resistance patterns of Canadian isolates. Antimicrob Agents Chemother 1981;19:593-7.
36. Gaudreau C, Gilbert H. Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp jejuni isolates from 1985 to 1997 in Quebec, Canada. Antimicrobial Agents Chemother 1998;42:2106-8. (Pubitemid 28363101)
37. Levesque S, Frost E, Michaud S. Comparison of antimicrobial resistance of Campylobacter jejuni isolated from humans, chickens, raw milk, and environmental water in Quebec. J Food Prot 2007;70:729-35. (Pubitemid 46446999)
38. Johnson J, McMullen L, Hasselback P, Louie M, Jhangri G, Saunders L. Risk factors for ciprofloxacin resistance in reported Campylobacter infections in southern Alberta. Epidemiol Infect 2007;136:903-12.
39. Boonmar S, Morita Y, Fujita M, et al. Serotypes, antimicrobial susceptibility, and gyr A gene mutation of Campylobacter jejuni isolates from humans and chickens in Thailand. Microbiol Immunol 2007;51:531-7. (Pubitemid 46799720)
40. Engberg J. Contributions to the epidemiology of Campylobacter infections. A review of clinical and microbiological studies. Dan Med Bull 2006;53:361-89. (Pubitemid 44816916)
41. Domingues AR, Pires SM, Halasa T, Hald T. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections. Epidemiol Infect 2012;140:970-81.
42. Olson CK, Ethelberg S, Van Pelt W, Tauxe RV. Epidemiology of Campylobacter jejuni infections in industrialized nations. In: Nachamkin I, Szymanski CM, Blaser MJ, eds. Campylobacter, 3rd edn. Washington, DC: ASM Press, 2008:163.
43. Friedman CR, Hoekstra RM, Samuel M, et al. Risk factors for sporadic Campylobacter infection in the United States: A case-control study in FoodNet sites. 2004;38(Suppl 3):S285-96.
44. Neimann J, Engberg J, Molbak K, Wegener HC. A case-control study of risk factors for sporadic Campylobacter infections in Denmark. Epidemiol Infect 2003;130:353-66. (Pubitemid 36722773)
45. Effler P, Ieong M, Kimura A, et al. Sporadic Campylobacter jejuni infections in Hawaii: Associations with prior antibiotic use and commercially prepared chicken. J Infect Dis 2001;183:1152-5. (Pubitemid 32230970)
46. de Haan CP, Kivisto RI, Hakkinen M, Corander J, Hanninen ML. Multilocus sequence types of Finnish bovine Campylobacter jejuni isolates and their attribution to human infections. BMC Microbiol 2010;10:200.
47. EFSA Panel on Biological Hazards. Scientific opinion on quantification of risk posed by broiler meat to human Campylobacteriosis in the EU. EFSA J 2010;8:1437-526.
48. Mullner P, Jones G, Noble A, Spencer SE, Hathaway S, French NP. Source attribution of food-borne zoonoses in New Zealand: A modified Hald model. Risk Anal 2009;29:970-84.
49. Deckert A, Valdivieso-Garcia A, Reid-Smith R, et al. Prevalence and antimicrobial resistance in Campylobacter spp. isolated from retail chicken in two health units in Ontario. J Food Prot 2010;73:1317-24.
50. Government of Canada. Surveillance bulletin - Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS): Emergence of ciprofloxacin-resistant Campylobacter in retail chicken in British Columbia and Saskatchewan. 〈www.phac-aspc.gc.ca/cipars-picra/bulletin-eng.php〉 (Accessed July 3, 2012).
51. Hakanen AJ, Lehtopolku M, Siitonen A, Huovinen P, Kotilainen P. Multidrug resistance in Campylobacter jejuni strains collected from Finnish patients during 1995-2000. J Antimicrob Chemother 2003;52:1035-9. (Pubitemid 38008431)
52. Gaudreau C, Gilbert H. Antimicrobial resistance of Campylobacter jejuni subsp. jejuni strains isolated from humans in 1998 to 2001 in Montreal, Canada. Antimicrob Agents Chemother 2003;47:2027-9. (Pubitemid 36637839)
53. Lariviere LA, Gaudreau CL, Turgeon FF. Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents. J Antimicrob Chemother 1986;18:681-5. (Pubitemid 17208855)
54. Taylor DE, Chang N, Garner RS, Sherburne R, Mueller L. Incidence of antibiotic resistance and characterization of plasmids in Campylobacter jejuni strains isolated from clinical sources in Alberta, Canada. Can J Microbiol 1986;32:28-32. (Pubitemid 16110022)
55. Sjogren E, Kaijser B, Werner M. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: A 10-year follow-up report. Antimicrob Agents Chemother 1992;36:2847-9.
56. Guevremont E, Nadeau E, Sirois M, Quessy S. Antimicrobial susceptibilities of thermophilic Campylobacter from humans, swine, and chicken broilers. Can J Vet Res 2006;70:81-6.
57. Keegan VA, Majowicz SE, Pearl DL, et al. Epidemiology of enteric disease in C-EnterNet's pilot site - Waterloo region, Ontario, 1990 to 2004. Can J Infect Dis Med Microbiol 2009;20:79-87.
58. Lee MB, Middleton D. Enteric illness in Ontario, Canada, from 1997 to 2001. J Food Prot 2003;66:953-61. (Pubitemid 36689325)
59. Ruzante JM, Majowicz SE, Fazil A, Davidson VJ. Hospitalization and deaths for select enteric illnesses and associated sequelae in Canada, 2001-2004. Epidemiol Infect 2011;139:937-45.
60. Wilson IG. Airborne Campylobacter infection in a poultry worker: Case report and review of the literature. Commun Dis Public Health 2004;7:349-53.
61. Skirrow MB. A demographic survey of Campylobacter, Salmonella and Shigella infections in England. A public health laboratory service survey. Epidemiol Infect 1987;99:647-57. (Pubitemid 18034338)
62. Samuel MC, Vugia DJ, Shallow S, et al. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996-1999. 2004;38(Suppl 3):S165-74.